APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Melatonin Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Long-acting Melatonin Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchLong-acting Melatonin Receptor Agonists Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Melatonin Receptor Agonists Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Long-acting Melatonin Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Melatonin Receptor Agonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Melatonin Receptor Agonists Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Long-acting Melatonin Receptor Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting Melatonin Receptor Agonists include Takeda, Sichuan Kelun Pharmaceuticals, Sichuan Guowei Pharmaceuticals, Novartis, Jiangsu Hausen Pharmaceuticals, Hangzhou Lingye Pharmaceutical Technology, Guangdong Annuo Pharmaceuticals, Vanda Pharmaceuticals and Servier Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Long-acting Melatonin Receptor Agonists market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-acting Melatonin Receptor Agonists and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-acting Melatonin Receptor Agonists revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Long-acting Melatonin Receptor Agonists market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-acting Melatonin Receptor Agonists Segment by Company

Takeda

Sichuan Kelun Pharmaceuticals

Sichuan Guowei Pharmaceuticals

Novartis

Jiangsu Hausen Pharmaceuticals

Hangzhou Lingye Pharmaceutical Technology

Guangdong Annuo Pharmaceuticals

Vanda Pharmaceuticals

Servier Laboratories

Rovi Pharma

Nectid Inc

Dr Reddy's Laboratories

Long-acting Melatonin Receptor Agonists Segment by Type

Ramelteon

Agomelatine

Other

Long-acting Melatonin Receptor Agonists Segment by Application

Hospital

Clinic

Other

Long-acting Melatonin Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Melatonin Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Melatonin Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Melatonin Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Long-acting Melatonin Receptor Agonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long-acting Melatonin Receptor Agonists industry.

Chapter 3: Detailed analysis of Long-acting Melatonin Receptor Agonists companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-acting Melatonin Receptor Agonistsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ramelteon Table 3. Key Players of Agomelatine Table 4. Key Players of Other Table 4. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2021-2026) Table 11. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2027-2032) Table 13. Long-acting Melatonin Receptor Agonists Industry Trends Table 14. Long-acting Melatonin Receptor Agonists Industry Drivers Table 15. Long-acting Melatonin Receptor Agonists Industry Opportunities and Challenges Table 16. Long-acting Melatonin Receptor Agonists Industry Restraints Table 17. Global Long-acting Melatonin Receptor Agonists Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Company (2021-2026) Table 19. Global Long-acting Melatonin Receptor Agonists Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Long-acting Melatonin Receptor Agonists Key Company Head Office and Area Served Table 21. Global Long-acting Melatonin Receptor Agonists Company, Product Type & Application Table 22. Global Long-acting Melatonin Receptor Agonists Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Long-acting Melatonin Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Long-acting Melatonin Receptor Agonists Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Type (2021-2026) Table 29. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Type (2027-2032) Table 30. Global Long-acting Melatonin Receptor Agonists Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Application (2021-2026) Table 34. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Long-acting Melatonin Receptor Agonists Product Portfolio Table 39. Takeda Recent Development Table 40. Sichuan Kelun Pharmaceuticals Company Information Table 41. Sichuan Kelun Pharmaceuticals Business Overview Table 42. Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 44. Sichuan Kelun Pharmaceuticals Recent Development Table 45. Sichuan Guowei Pharmaceuticals Company Information Table 46. Sichuan Guowei Pharmaceuticals Business Overview Table 47. Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 49. Sichuan Guowei Pharmaceuticals Recent Development Table 50. Novartis Company Information Table 51. Novartis Business Overview Table 52. Novartis Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis Long-acting Melatonin Receptor Agonists Product Portfolio Table 54. Novartis Recent Development Table 55. Jiangsu Hausen Pharmaceuticals Company Information Table 56. Jiangsu Hausen Pharmaceuticals Business Overview Table 57. Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 59. Jiangsu Hausen Pharmaceuticals Recent Development Table 60. Hangzhou Lingye Pharmaceutical Technology Company Information Table 61. Hangzhou Lingye Pharmaceutical Technology Business Overview Table 62. Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Product Portfolio Table 64. Hangzhou Lingye Pharmaceutical Technology Recent Development Table 65. Guangdong Annuo Pharmaceuticals Company Information Table 66. Guangdong Annuo Pharmaceuticals Business Overview Table 67. Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 69. Guangdong Annuo Pharmaceuticals Recent Development Table 70. Vanda Pharmaceuticals Company Information Table 71. Vanda Pharmaceuticals Business Overview Table 72. Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 74. Vanda Pharmaceuticals Recent Development Table 75. Servier Laboratories Company Information Table 76. Servier Laboratories Business Overview Table 77. Servier Laboratories Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Servier Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio Table 79. Servier Laboratories Recent Development Table 80. Rovi Pharma Company Information Table 81. Rovi Pharma Business Overview Table 82. Rovi Pharma Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Rovi Pharma Long-acting Melatonin Receptor Agonists Product Portfolio Table 84. Rovi Pharma Recent Development Table 85. Nectid Inc Company Information Table 86. Nectid Inc Business Overview Table 87. Nectid Inc Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Nectid Inc Long-acting Melatonin Receptor Agonists Product Portfolio Table 89. Nectid Inc Recent Development Table 90. Dr Reddy's Laboratories Company Information Table 91. Dr Reddy's Laboratories Business Overview Table 92. Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio Table 94. Dr Reddy's Laboratories Recent Development Table 95. North America Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) Table 101. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032) Table 102. Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) Table 108. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032) Table 109. China Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 110. China Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 111. China Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 112. China Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) Table 119. Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Long-acting Melatonin Receptor Agonists Product Image Figure 2. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Long-acting Melatonin Receptor Agonists Market Share by Type: 2025 VS 2032 Figure 4. Ramelteon Image Figure 5. Agomelatine Image Figure 6. Other Image Figure 7. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Long-acting Melatonin Receptor Agonists Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Long-acting Melatonin Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 14. Global Long-acting Melatonin Receptor Agonists Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Long-acting Melatonin Receptor Agonists Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Long-acting Melatonin Receptor Agonists Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 21. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 23. North America Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 24. North America Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032) Figure 25. North America Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032) Figure 26. North America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 27. United States Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 28. Canada Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 30. Europe Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 31. Europe Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032) Figure 32. Europe Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032) Figure 33. Europe Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 34. Germany Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 35. France Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 37. Italy Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 38. Russia Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 40. China Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 41. China Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032) Figure 42. China Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032) Figure 43. Asia Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 44. Asia Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032) Figure 45. Asia Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032) Figure 46. Asia Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 47. Japan Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 51. India Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 52. Australia Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 57. Brazil Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 62. UAE Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 64. Chile Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Ramelteon
  • Agomelatine
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Takeda
  • Sichuan Kelun Pharmaceuticals
  • Sichuan Guowei Pharmaceuticals
  • Novartis
  • Jiangsu Hausen Pharmaceuticals
  • Hangzhou Lingye Pharmaceutical Technology
  • Guangdong Annuo Pharmaceuticals
  • Vanda Pharmaceuticals
  • Servier Laboratories
  • Rovi Pharma
  • Nectid Inc
  • Dr Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ramelteon
  5. 1.2.3 Agomelatine
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Long-acting Melatonin Receptor Agonists Growth Trends by Region
  14. 1.5.1 Global Long-acting Melatonin Receptor Agonists Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
  16. 1.5.3 Long-acting Melatonin Receptor Agonists Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Long-acting Melatonin Receptor Agonists Market Dynamics
  1. 2.1 Long-acting Melatonin Receptor Agonists Industry Trends
  2. 2.2 Long-acting Melatonin Receptor Agonists Industry Drivers
  3. 2.3 Long-acting Melatonin Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 Long-acting Melatonin Receptor Agonists Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Long-acting Melatonin Receptor Agonists Revenue by Company (2021-2026)
  2. 3.2 Global Long-acting Melatonin Receptor Agonists Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Long-acting Melatonin Receptor Agonists Key Company Head office and Area Served
  4. 3.4 Global Long-acting Melatonin Receptor Agonists Company, Product Type & Application
  5. 3.5 Global Long-acting Melatonin Receptor Agonists Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Long-acting Melatonin Receptor Agonists Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Long-acting Melatonin Receptor Agonists Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Long-acting Melatonin Receptor Agonists Tier 1, Tier 2, and Tier 3
4 Long-acting Melatonin Receptor Agonists Market by Type
  1. 4.1 Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2032)
  3. 4.3 Global Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032)
5 Long-acting Melatonin Receptor Agonists Market by Application
  1. 5.1 Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2032)
  3. 5.3 Global Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Long-acting Melatonin Receptor Agonists Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sichuan Kelun Pharmaceuticals
  8. 6.2.1 Sichuan Kelun Pharmaceuticals Company Information
  9. 6.2.2 Sichuan Kelun Pharmaceuticals Business Overview
  10. 6.2.3 Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  12. 6.2.5 Sichuan Kelun Pharmaceuticals Recent Developments
  13. 6.3 Sichuan Guowei Pharmaceuticals
  14. 6.3.1 Sichuan Guowei Pharmaceuticals Company Information
  15. 6.3.2 Sichuan Guowei Pharmaceuticals Business Overview
  16. 6.3.3 Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  18. 6.3.5 Sichuan Guowei Pharmaceuticals Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Long-acting Melatonin Receptor Agonists Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Jiangsu Hausen Pharmaceuticals
  26. 6.5.1 Jiangsu Hausen Pharmaceuticals Company Information
  27. 6.5.2 Jiangsu Hausen Pharmaceuticals Business Overview
  28. 6.5.3 Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  30. 6.5.5 Jiangsu Hausen Pharmaceuticals Recent Developments
  31. 6.6 Hangzhou Lingye Pharmaceutical Technology
  32. 6.6.1 Hangzhou Lingye Pharmaceutical Technology Company Information
  33. 6.6.2 Hangzhou Lingye Pharmaceutical Technology Business Overview
  34. 6.6.3 Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Product Portfolio
  36. 6.6.5 Hangzhou Lingye Pharmaceutical Technology Recent Developments
  37. 6.7 Guangdong Annuo Pharmaceuticals
  38. 6.7.1 Guangdong Annuo Pharmaceuticals Company Information
  39. 6.7.2 Guangdong Annuo Pharmaceuticals Business Overview
  40. 6.7.3 Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  42. 6.7.5 Guangdong Annuo Pharmaceuticals Recent Developments
  43. 6.8 Vanda Pharmaceuticals
  44. 6.8.1 Vanda Pharmaceuticals Company Information
  45. 6.8.2 Vanda Pharmaceuticals Business Overview
  46. 6.8.3 Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  48. 6.8.5 Vanda Pharmaceuticals Recent Developments
  49. 6.9 Servier Laboratories
  50. 6.9.1 Servier Laboratories Company Information
  51. 6.9.2 Servier Laboratories Business Overview
  52. 6.9.3 Servier Laboratories Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Servier Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio
  54. 6.9.5 Servier Laboratories Recent Developments
  55. 6.10 Rovi Pharma
  56. 6.10.1 Rovi Pharma Company Information
  57. 6.10.2 Rovi Pharma Business Overview
  58. 6.10.3 Rovi Pharma Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Rovi Pharma Long-acting Melatonin Receptor Agonists Product Portfolio
  60. 6.10.5 Rovi Pharma Recent Developments
  61. 6.11 Nectid Inc
  62. 6.11.1 Nectid Inc Company Information
  63. 6.11.2 Nectid Inc Business Overview
  64. 6.11.3 Nectid Inc Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Nectid Inc Long-acting Melatonin Receptor Agonists Product Portfolio
  66. 6.11.5 Nectid Inc Recent Developments
  67. 6.12 Dr Reddy's Laboratories
  68. 6.12.1 Dr Reddy's Laboratories Company Information
  69. 6.12.2 Dr Reddy's Laboratories Business Overview
  70. 6.12.3 Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio
  72. 6.12.5 Dr Reddy's Laboratories Recent Developments
7 North America
  1. 7.1 North America Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  2. 7.2 North America Long-acting Melatonin Receptor Agonists Market Size by Type
  3. 7.2.1 North America Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
  4. 7.2.2 North America Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032)
  5. 7.2.3 North America Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032)
  6. 7.3 North America Long-acting Melatonin Receptor Agonists Market Size by Application
  7. 7.3.1 North America Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
  8. 7.3.2 North America Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032)
  9. 7.3.3 North America Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032)
  10. 7.4 North America Long-acting Melatonin Receptor Agonists Market Size by Country
  11. 7.4.1 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  13. 7.4.3 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032)
  14. 7.4.4 North America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  2. 8.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Type
  3. 8.2.1 Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
  4. 8.2.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032)
  5. 8.2.3 Europe Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032)
  6. 8.3 Europe Long-acting Melatonin Receptor Agonists Market Size by Application
  7. 8.3.1 Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
  8. 8.3.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032)
  9. 8.3.3 Europe Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032)
  10. 8.4 Europe Long-acting Melatonin Receptor Agonists Market Size by Country
  11. 8.4.1 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  13. 8.4.3 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032)
  14. 8.4.4 Europe Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  2. 9.2 China Long-acting Melatonin Receptor Agonists Market Size by Type
  3. 9.2.1 China Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
  4. 9.2.2 China Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032)
  5. 9.2.3 China Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032)
  6. 9.3 China Long-acting Melatonin Receptor Agonists Market Size by Application
  7. 9.3.1 China Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
  8. 9.3.2 China Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032)
  9. 9.3.3 China Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  2. 10.2 Asia Long-acting Melatonin Receptor Agonists Market Size by Type
  3. 10.2.1 Asia Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
  4. 10.2.2 Asia Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032)
  5. 10.2.3 Asia Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032)
  6. 10.3 Asia Long-acting Melatonin Receptor Agonists Market Size by Application
  7. 10.3.1 Asia Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
  8. 10.3.2 Asia Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032)
  9. 10.3.3 Asia Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032)
  10. 10.4 Asia Long-acting Melatonin Receptor Agonists Market Size by Country
  11. 10.4.1 Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  13. 10.4.3 Asia Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032)
  14. 10.4.4 Asia Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst